Curve Therapeutics Co-Founder and CSO Professor Ali Tavassoli awarded the Royal Society of Chemistry’s Interdisciplinary Prize Curve Therapeutics proudly announced that Professor Ali Tavassoli, its Co-Founder and Chief Scientific Officer, has been awarded the Interdisciplinary Prize by the Royal Society of Chemistry in recognition of his brilliance in research and innovation, and contribution to scientific […]
Midsummer is here and it is glorious! The daylight seems eternal, and it seems these endless days will last forever too. London is a city of light, with the sun bouncing off ten thousand windows. Is it even the same place as the London of six months ago? The further north you go, the […]
Rewind Therapeutics strengthens scientific advisory board with leading international neurology experts as it advances its first-in-class remyelination therapy Rewind Therapeutics, which is developing first-in-class treatments for demyelination-associated diseases, has appointed four internationally recognised innovators in neurology – Professors Shiv Saidha, Cristina Granziera, David Leppert, and Roberto Furlan – to its Scientific Advisory Board (SAB). The […]
Thursday June 12 was Global Fatty Liver Day. But until 2018 it was known as International NASH Day – NASH being short for ‘non-alcoholic steatohepatitis’. The name of the awareness day was changed to increase awareness of all types of fatty liver disease, as NASH is just one type – a more serious type – […]
SpliceBio secures $135 Million Series B financing to advance lead program SB-007 in Stargardt disease and expand pipeline of genetic medicines SpliceBio, a clinical-stage genetic medicines company pioneering Protein Splicing to address diseases caused by mutations in large genes, announced the close of a $135 million Series B financing co-led by new investors EQT Life Sciences and Sanofi […]
